Hugh Burrill provides consulting services in pharmaceutical management, product development, regulatory affairs and intellectual property.
Mr Burrill was the corporate vice president of global pharma research & development at Hospira Inc where he was part of overall pipeline portfolio management, and research and development of specialty pharmaceuticals. Prior to that, he held senior international roles within Hospira Inc and the original Mayne Pharma.